EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanotechnology as a potential treatment for diabetes and its complications: A review

Kanika Manral, Anita Singh, Yuvraj Singh

Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2024-11 · 18 (11-12) · 103159

DOI: 10.1016/j.dsx.2024.103159 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024-11. Verfasst von Kanika Manral und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Technology Sir J.C Bose Technical Campus Bhimtal, Kumaun University Nainital, 263136, India. Electr…. Hauptthemen laut MEDLINE: Diabetes Complications, Diabetes Mellitus, Nanotechnology, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 114 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Diabetes mellitus is a chronic metabolic disorder that causes multiple complications in various organs, such as the kidney, liver and cardiovascular system. These complications are the main causes of morbidity and mortality in patients with diabetes. Nanotechnology offers new opportunities for the therapy of diabetes and its multiple complications through site-specific and precise drug delivery. This review summarizes the various studies demonstrating the potential applications of different nanoparticles in diabetes-associated complications. METHOD: A literature search was conducted using PubMed, Google Scholar and Scopus databases, focusing on the role of nanoparticles in the improved delivery of various hypoglycemic agents for the treatment of microvascular and macrovascular diabetic complications. RESULTS: Numerous studies have shown that nanoparticles, such as nanoliposomes, polymeric micelles, dendrimers and metallic nanoparticles, improve the delivery of various hypoglycemic agents. Moreover, nanoparticles have been found to be safer, with improved pharmacokinetic and pharmacodynamic profiles. CONCLUSION: This review outlines the significant role of nanotechnology in diabetes and related complications and its superiority over conventional drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes ComplicationsDiabetes MellitusNanotechnologyNanoparticle Drug Delivery SystemAnimalsHumansHypoglycemic Agents

Stichwörter der Autor:innen

Diabetes mellitusDiabetic complicationNanoparticleNanotechnology

Substanzen

Hypoglycemic AgentsNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Faculty of Technology Sir J.C Bose Technical Campus Bhimtal, Kumaun University Nainital, 263136, India. Electronic address: kanikamanral.009@gmail.com.
  • Department of Pharmaceutical Sciences, Faculty of Technology Sir J.C Bose Technical Campus Bhimtal, Kumaun University Nainital, 263136, India. Electronic address: anitapharma4@gmail.com.
  • Department of Pharmacy, BITS-Pilani, Hyderabad Campus, Medchal, Hyderabad, 500078, India. Electronic address: yuvraj.singh@hyderabad.bits-pilani.ac.in.

Zitieren

APA

Manral, K., Singh, A., & Singh, Y. (2024). Nanotechnology as a potential treatment for diabetes and its complications: A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 18(11-12), 103159. https://doi.org/10.1016/j.dsx.2024.103159

Vancouver

Manral K, Singh A, Singh Y. Nanotechnology as a potential treatment for diabetes and its complications: A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2024;18(11-12):103159. doi:10.1016/j.dsx.2024.103159

BibTeX
@article{Manral2024,
  author = {Manral, Kanika and Singh, Anita and Singh, Yuvraj},
  title = {Nanotechnology as a potential treatment for diabetes and its complications: A review},
  journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
  year = {2024},
  volume = {18},
  number = {11-12},
  pages = {103159},
  doi = {10.1016/j.dsx.2024.103159}
}
Kostenlos starten →